Overview
- 14 FDA inspections are on record.
- 6 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-01-15.
At a glance
Inspections
14
Form 483s
6
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 8 Jan 2025 – 15 Jan 2025 | Human Drugs | 483 | View 483 → |
| 24 Feb 2020 – 28 Feb 2020 | Human Drugs | 483 | View 483 → |
| 26 Apr 2018 – 4 May 2018 | Human Drugs | Clean | |
| 7 Mar 2017 – 8 Mar 2017 | Human Drugs | Clean | |
| 3 Aug 2015 – 7 Aug 2015 | Human Drugs | 483 | View 483 → |
| 8 Jul 2014 | Human Drugs | Clean | |
| 22 Jul 2013 – 1 Aug 2013 | Human Drugs | Clean | |
| 5 Apr 2012 | Not recorded | 483 | View 483 → |
| 23 Mar 2011 | Not recorded | 483 | View 483 → |
| 29 Oct 2009 | Not recorded | 483 | View 483 → |
| 10 Aug 2007 | Not recorded | Clean | |
| 20 May 2005 | Not recorded | Clean | |
Observations on record
Form 483 observations cited at this site, most recent first.
15 Jan 2025
21 CFR 211.110(d)
Rejected in-process materials not quarantined
Cited by Pushpa S Jayasekara
15 Jan 2025
21 CFR 211.186(a)
Signature and checking of records -- 2 persons
Cited by Pushpa S Jayasekara
15 Jan 2025
21 CFR 211.188(b)(11)
Identification of Persons Performing Significant Steps
Cited by Pushpa S Jayasekara
15 Jan 2025
FDCA 582(b)(4)
Systems in place to comply with verifciation requirements
Cited by Pushpa S Jayasekara
Investigators
FDA investigators tied to this site in the record.
Marcus A Ray2 insp.
Nebil A Oumer2 insp.
Rachel C Harrington2 insp.
Pushpa S Jayasekara1 insp.
Roseline N Boateng1 insp.
Marcia D Fields1 insp.
Michael A Taylor1 insp.
Michael L Casner1 insp.
Eric L Dong1 insp.
Deborah J Parris1 insp.
Clarice J Ahn1 insp.
Joey C West1 insp.
Brooke K Higgins1 insp.
Ernest Bizjak1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.113(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.198(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.25(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.67(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 514.80(b)(1) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.110(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.110(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.115(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.122(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(f) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.166(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.166(a)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.180(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.186(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188(b)(11) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.204 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(a) | Cited across public-safe Form 483 observations | 1x |
| FDCA 582(b)(4) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Jubilant Cadista Pharmaceuticals, Inc.'s 6 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat